PK & PD Analysis - Pharmakinetic Ltd

Improving Dose Selection

Using our extensive experience, we can design, analyse, and report your pharmacokinetic studies so that they provide clarity on future drug development strategy.

Our quality systems ensure the integrity of all our analyses and reports.

We use industry standard software (Phoenix™ WinNonlin®) to aid our non-compartmental analysis and PK & PD modelling and simulation.

We understand the need to relate drug concentration to clinical effect (beneficial and adverse) to aid selection of a safe and effective dose.

Enhancing your Decision-Making

Clients benefit from PharmaKinetic’s contributions in the following areas:

Safety Review

Interim PK & PD analysis and reporting for input into safety review meetings during dose escalation studies

End of Study Analysis

Non-compartmental analysis of PK & PD data from clinical pharmacology studies

Drug Concentration: Effect Relationships

PK/PD modelling of drug concentration data against pharmacodynamic markers in animals and humans

Dose Selection

Modelling and simulation to justify dose selection for future clinical studies

Clinical Study Reports

Contributing to PK & PD sections of clinical study reports. Standalone PK reporting including TFLs

Pre-clinical analysis

PK and TK data analysis and reporting for all your Discovery needs

Contact Us Today

Unlock your drug’s potential with our pharmacokinetic expertise